Posts Tagged ‘Quintiles’
RTP Wrapup 12/4
Thursday, December 3, 2009, 11:07 pm No Comments | Post a CommentWinston-Salem drug development company Targacept adds a $1.24 billion deal to its partnship with British drugmaker AstraZeneca, Quintiles Transnational will add $400 million in debt to pay dividend and an AIDS researcher dares to speak of a cure. Read more…
RTP Wrapup 11/6
Thursday, November 5, 2009, 5:40 pm No Comments | Post a CommentQuintiles Transnational scores drug research contracts that cover whole development areas, Stiefel Laboratories shutters operations in Florida and Georgia and consolidates efforts in Research Triangle Park and a symposium organized by RTI International exposes research gaps.
RTP Wrapup 10/23
Thursday, October 22, 2009, 5:43 pm No Comments | Post a CommentWorries of Tysabri’s side effect risks are on the rise, BDSI goes on a publicity blitz to boost its stock and Trimeris finds a potential buyer.
Q&A with Sandy Kennedy
Thursday, September 10, 2009, 7:39 pm No Comments | Post a CommentSandy Kennedy is an executive at Quintiles Transnational, where she is charged with making sure that studies testing new medicines follow federal and industry regulations and guidelines.
Governor wants incentives for entrepreneurs
Thursday, May 28, 2009, 4:10 pm No Comments | Post a CommentGov. Beverly Perdue used a ribbon cutting Thursday to propose state incentives to encourage scientists to become entrepreneurs.
Purdue seized the grand opening of Quintiles Transnational‘s new global headquarters in Durham to talk about a founder’s tax credit and small innovation research grants she said she wants legislators to pass during the ongoing session.
